» Articles » PMID: 30626103

Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jan 11
PMID 30626103
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

This article provides an overview of neuroimaging biomarkers in experimental epileptogenesis and refractory epilepsy. Neuroimaging represents a gold standard and clinically translatable technique to identify neuropathological changes in epileptogenesis and longitudinally monitor its progression after a precipitating injury. Neuroimaging studies, along with molecular studies from animal models, have greatly improved our understanding of the neuropathology of epilepsy, such as the hallmark hippocampus sclerosis. Animal models are effective for differentiating the different stages of epileptogenesis. Neuroimaging in experimental epilepsy provides unique information about anatomic, functional, and metabolic alterations linked to epileptogenesis. Recently, several in vivo biomarkers for epileptogenesis have been investigated for characterizing neuronal loss, inflammation, blood-brain barrier alterations, changes in neurotransmitter density, neurovascular coupling, cerebral blood flow and volume, network connectivity, and metabolic activity in the brain. Magnetic resonance imaging (MRI) is a sensitive method for detecting structural and functional changes in the brain, especially to identify region-specific neuronal damage patterns in epilepsy. Positron emission tomography (PET) and single-photon emission computerized tomography are helpful to elucidate key functional alterations, especially in areas of brain metabolism and molecular patterns, and can help monitor pathology of epileptic disorders. Multimodal procedures such as PET-MRI integrated systems are desired for refractory epilepsy. Validated biomarkers are warranted for early identification of people at risk for epilepsy and monitoring of the progression of medical interventions.

Citing Articles

Krüppel-like factors: potential roles in blood-brain barrier dysfunction and epileptogenesis.

Santos A, Carona A, Ettcheto M, Camins A, Falcao A, Fortuna A Acta Pharmacol Sin. 2024; 45(9):1765-1776.

PMID: 38684799 PMC: 11335766. DOI: 10.1038/s41401-024-01285-w.


The Neurovascular Unit Dysfunction in the Molecular Mechanisms of Epileptogenesis and Targeted Therapy.

Liu X, Zhang Y, Zhao Y, Zhang Q, Han F Neurosci Bull. 2024; 40(5):621-634.

PMID: 38564049 PMC: 11127907. DOI: 10.1007/s12264-024-01193-3.


A longitudinal MRI and TSPO PET-based investigation of brain region-specific neuroprotection by diazepam versus midazolam following organophosphate-induced seizures.

Hobson B, Rowland D, Dou Y, Saito N, Harmany Z, Bruun D Neuropharmacology. 2024; 251:109918.

PMID: 38527652 PMC: 11250911. DOI: 10.1016/j.neuropharm.2024.109918.


Quantitative T mapping-based longitudinal assessment of brain injury and therapeutic rescue in the rat following acute organophosphate intoxication.

Almeida A, Hobson B, Saito N, Bruun D, Porter V, Harvey D Neuropharmacology. 2024; 249:109895.

PMID: 38437913 PMC: 11227117. DOI: 10.1016/j.neuropharm.2024.109895.


Interictal magnetic signals in new-onset Rolandic epilepsy may help with timing of treatment selection.

Xu F, Li Y, Wang Y, Wang S, Sun F, Wang X Epilepsia Open. 2023; 9(1):368-379.

PMID: 38145506 PMC: 10839299. DOI: 10.1002/epi4.12884.


References
1.
Kornblum H, Araujo D, Annala A, Tatsukawa K, Phelps M, Cherry S . In vivo imaging of neuronal activation and plasticity in the rat brain by high resolution positron emission tomography (microPET). Nat Biotechnol. 2000; 18(6):655-60. DOI: 10.1038/76509. View

2.
Roch C, Leroy C, Nehlig A, Namer I . Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats. Epilepsia. 2002; 43(4):325-35. DOI: 10.1046/j.1528-1157.2002.11301.x. View

3.
Wolf O, Dyakin V, Patel A, Vadasz C, de Leon M, McEwen B . Volumetric structural magnetic resonance imaging (MRI) of the rat hippocampus following kainic acid (KA) treatment. Brain Res. 2002; 934(2):87-96. DOI: 10.1016/s0006-8993(02)02363-6. View

4.
Roch C, Leroy C, Nehlig A, Namer I . Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine model. Epilepsia. 2002; 43(10):1129-36. DOI: 10.1046/j.1528-1157.2002.17802.x. View

5.
Herman S . Epilepsy after brain insult: targeting epileptogenesis. Neurology. 2002; 59(9 Suppl 5):S21-6. DOI: 10.1212/wnl.59.9_suppl_5.s21. View